Suppr超能文献

4D-CT 在胃黏膜相关边缘区 B 细胞淋巴瘤/黏膜相关淋巴组织淋巴瘤放射治疗计划中的应用价值。

Usefulness of 4D-CT for radiation treatment planning of gastric MZBCL/MALT.

机构信息

Department of Radiology, Kanazawa Medical University, Kahoku, Ishikawa 920-0293, Japan.

出版信息

J Radiat Res. 2012;53(2):333-7. doi: 10.1269/jrr.11127. Epub 2012 Mar 15.

Abstract

It is well known that significant variations in stomach size, shape, and respiratory motion lead to uncertainties in target localization during treatment for gastric lymphoma. In this study, the usefulness of 4D-CT for radiation planning of gastric MZBCL/MALT was evaluated. Treatment planning using 4DCT (plan A) and conventional planning with a uniform margin (plan B) were compared using dose volume histograms (DVH) of the planning target volume (PTV) and the organ at risk, as well as the dose coverage of the clinical target volume (CTV) assessed by weekly online cone beam CT (CBCT) during the treatment course. In addition, regarding the image quality of CBCT , the interobserver agreement for the delineated volume of the CTV on CBCT was analyzed. The mean PTV of plan A was significantly smaller than that of plan B (p = 0.008). The mean doses to the liver and heart in plan A were significantly lower than those in plan B (p = 0.02 and 0.03, respectively). The reductions of V(20) of each kidney in plan A compared with those in plan B were 4.8 ± 2.4% in the right kidney and 16.3 ± 10.4% in the left. There was no significant difference in the dose coverage of the CTV between the plans during the treatment course. The interobserver agreement for the volume of the CTV was moderate correlation. Treatment planning using 4DCT for gastric MZBCL/MALT was useful for effective and safe irradiation with minimizing exposure of the organ at risk.

摘要

众所周知,胃的大小、形状和呼吸运动的显著变化会导致胃淋巴瘤治疗过程中靶区定位的不确定性。本研究评估了 4D-CT 在胃黏膜相关边缘区 B 细胞淋巴瘤/黏膜相关淋巴组织淋巴瘤(MALT)放射治疗计划中的作用。通过剂量体积直方图(DVH)比较了 4DCT 治疗计划(计划 A)和常规均匀边界治疗计划(计划 B)对计划靶区(PTV)和危及器官的影响,以及通过每周在线锥形束 CT(CBCT)在治疗过程中评估的临床靶区(CTV)的剂量覆盖情况。此外,关于 CBCT 的图像质量,还分析了观察者间勾画 CTV 体积的一致性。计划 A 的 PTV 平均值明显小于计划 B(p = 0.008)。计划 A 中肝脏和心脏的平均剂量明显低于计划 B(p = 0.02 和 0.03)。与计划 B 相比,计划 A 中每个肾脏的 V20 降低了 4.8±2.4%(右肾)和 16.3±10.4%(左肾)。在治疗过程中,两个计划的 CTV 剂量覆盖没有显著差异。CTV 体积的观察者间一致性为中度相关。对于胃 MZBCL/MALT,使用 4DCT 进行治疗计划有助于进行有效和安全的照射,同时最大限度地减少危及器官的暴露。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验